The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism

Fibroblast growth factor-23 (FGF23), a phosphate(Phos)-regulating hormone, is abnormally elevated in hypophosphataemic syndromes and an elevated FGF23 is a predictor of mortality in kidney disease. Recent findings suggest iron deficiency as a potential mediator of FGF23 expression and murine studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Braithwaite, V.S., Prentice, A., Darboe, M.K., Prentice, A.M., Moore, S.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2016
Materias:
Original Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720219/
https://www.ncbi.nlm.nih.gov/pubmed/26453792
http://dx.doi.org/10.1016/j.bone.2015.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720219/
https://www.ncbi.nlm.nih.gov/pubmed/26453792
http://dx.doi.org/10.1016/j.bone.2015.10.003

Ejemplares similares